Table 4.
Factors associated with technology acceptance.
| Factors | Perceived usefulness, ORa (95% CI) | Perceived ease of use, OR (95% CI) | Attitude toward use, OR (95% CI) | Intention to use, OR (95% CI) | |
| Age (y) | 1.01 (0.96-1.06) | 0.97 (0.92-1.02) | 1.01 (0.97-1.07) | 0.99 (0.95-1.02) | |
| Sex | |||||
|
|
Male | Reference | Reference | Reference | Reference |
|
|
Female | 0.8 (0.32-1.96) | 0.58 (0.23-1.43) | 1 (0.38-2.63) | 0.62 (0.28-1.37) |
| Race | |||||
|
|
Racial and ethnic minority individuals | Reference | Reference | Reference | Reference |
|
|
White | 3.29 (0.96-11.28) | 1.9 (0.53-6.8) | 2.25 (0.61-8.25) | 2.32 (0.79-6.77) |
| Marital status | |||||
|
|
Currently unmarried | Reference | Reference | Reference | Reference |
|
|
Currently married or living as married | 0.27 (0.09-0.81) b | 0.34 (0.12-1) | 0.86 (0.29-2.54) | 0.81 (0.34-1.88) |
| Educational background | |||||
|
|
Grade school, high school, or some college | Reference | Reference | Reference | Reference |
|
|
College graduate or postgraduate | 2.55 (1.06-6.12) | 1.56 (0.67-3.63) | 1.89 (0.75-4.8) | 1.22 (0.59-2.51) |
| Occupation | |||||
|
|
Unemployed, retired, disabled, or others | Reference | Reference | Reference | Reference |
|
|
Full-time or part-time employee | 6.64 (1.65-26.79) | 4 (1.05-15.17) | 2.24 (0.64-7.84) | 3.4 (1.26-9.19) |
| Taking OAAsc currently or previously | |||||
|
|
No | Reference | Reference | Reference | Reference |
|
|
Yes | 1.05 (0.43-2.56) | 1.07 (0.44-2.61) | 1.37 (0.53-3.53) | 1.55 (0.72-3.37) |
| Taking other medications currently | |||||
|
|
No | Reference | Reference | Reference | Reference |
|
|
Yes | 1.85 (0.77-4.45) | 1.53 (0.63-3.71) | 4.23 (1.63-10.99) | 1.43 (0.65-3.17) |
| Medication safety perception | 2.01 (0.64-6.36) | 3.37 (1.07-10.58) | 0.74 (0.2-2.68) | 0.51 (0.17-1.47) | |
| Perceived safety of communication with a physician | 3.59 (1.52-8.48) | 2.44 (1.05-5.68) | 9.06 (2.95-27.84) | 2.68 (1.17-6.11) | |
| Self-rated health | |||||
|
|
Poor or fair | Reference | Reference | Reference | Reference |
|
|
Good, very good, or excellent | 1.86 (0.76-4.58) | 2.4 (0.99-5.78) | 1.85 (0.7-4.86) | 1.23 (0.58-2.62) |
| Patient activation | 1.02 (0.58-1.81) | 1.08 (0.61-1.92) | 1.09 (0.6-1.99) | 1.83 (1.12-2.98) | |
| Medication self-management | 0.91 (0.71-1.16) | 1 (0.79-1.27) | 1.02 (0.79-1.33) | 1.19 (0.97-1.46) | |
| Experience of web-based self-reporting system | |||||
|
|
No | Reference | Reference | Reference | Reference |
|
|
Yes | 1.9 (0.76-4.75) | 2.2 (0.88-5.48) | 1.14 (0.44-2.93) | 3.8 (1.73-8.36) |
| Perceived importance of feedback | |||||
|
|
Others | Reference | Reference | Reference | Reference |
|
|
Very important | 2.59 (1.03-6.51) | 2.5 (1-6.29) | 2.99 (1.11-8.05) | 3.27 (1.37-7.78) |
| Influence of others’ self-reporting responses | |||||
|
|
Not at all or do not know | Reference | Reference | Reference | Reference |
|
|
A lot or little | 2.53 (1.08-5.91) | 2.13 (0.92-4.92) | 3.36 (1.3-8.68) | 1.12 (0.55-2.3) |
aOR: odds ratio.
bItalicized values denote the statistical significance of the P value (P<.05).
cOAA: oral anticancer agent.